Robert Peter Campbell
Plus aucun poste en cours
Profil
Robert Peter Campbell served as Chairman of Sonic Healthcare Ltd.
from 2012 to 2015.
He also served as Chairman of St. Laurence Ltd.
and as an Independent Non-Executive Director of Guardian Medical Solutions Ltd.
from 2011 to 2014.
Additionally, he was a Non-Executive Director of CB Australia Ltd.
from 2007 to 2008, and an Independent Non-Executive Director of Silex Systems Ltd.
from 1996 to 2013.
He also served as a Director of SciGen Pte Ltd.
from 1999 to 2005.
Anciens postes connus de Robert Peter Campbell
| Sociétés | Poste | Fin |
|---|---|---|
| SONIC HEALTHCARE LIMITED | Président | 19/11/2015 |
| QRXPHARMA LTD. | Directeur/Membre du Conseil | 10/07/2014 |
| SILEX SYSTEMS LIMITED | Président | - |
CB Australia Ltd.
 CB Australia Ltd. Financial ConglomeratesFinance CB Australia Ltd. engaged in corporate activities. It is continued to unwind its past activities. The company was founded on May 11, 1984 and is headquartered in Sydney, Australia. | Directeur/Membre du Conseil | 01/10/2008 |
| SCIGEN LIMITED | Directeur/Membre du Conseil | 01/02/2005 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SONIC HEALTHCARE LIMITED | Health Services |
| SILEX SYSTEMS LIMITED | Electronic Technology |
| Entreprise privées | 4 |
|---|---|
Guardian Medical Solutions Ltd.
 Guardian Medical Solutions Ltd. Pharmaceuticals: MajorHealth Technology Guardian Medical Solutions Ltd. engages in the development and commercialization of biopharmaceutical products. The company was founded by Michael Anthony Quinn and Felix de la Iglesia on September 19, 2002 and is headquartered in Sydney, Australia. | Health Technology |
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
CB Australia Ltd.
CB Australia Ltd. Financial ConglomeratesFinance CB Australia Ltd. engaged in corporate activities. It is continued to unwind its past activities. The company was founded on May 11, 1984 and is headquartered in Sydney, Australia. | Finance |
St. Laurence Ltd.
 St. Laurence Ltd. Financial ConglomeratesFinance St. Laurence Ltd. provides investment and financial services. It offers aged and community care services, advanced career training, and housing services. The company was founded in 2001 and is headquartered in Millers Point, Australia. | Finance |
